A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)

PURPOSE: Antivascular endothelial growth factor agents are increasingly used in diabetic macular oedema (DME); however, there are few studies exploring their use in DME in real‐world settings. METHODS: POLARIS was a noninterventional, multicentre study to monitor 12‐month outcomes in patients starti...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanickova, Jana, Cunha‐Vaz, Jose, Ulbig, Michael, Pearce, Ian, Fernández‐Vega Sanz, Alvaro, Theodossiadis, Panagiotis, Kodjikian, Laurent, Izmailov, Alexander, Muston, Dominic, Vassilev, Zdravko, Lamotte, Benedicte, Tückmantel, Claudia, Friedl, Sabine, Altemark, Andreas, Schwarz, Hans‐Jörg, Katz, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585847/
https://www.ncbi.nlm.nih.gov/pubmed/29696809
http://dx.doi.org/10.1111/aos.13771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585847/
https://www.ncbi.nlm.nih.gov/pubmed/29696809
http://dx.doi.org/10.1111/aos.13771

Ejemplares similares